• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性心包积液患者的临床和影像学特征的预后和作用:中国单中心研究。

Prognosis and role of clinical and imaging features in patients with malignant pericardial effusion: a single-center study in China.

机构信息

Department of Cardiology, The Fourth Hospital of Hebei Medical University, 12 Health Road, Shijiazhuang, Hebei, 050011, People's Republic of China.

Department of Orthopedics, The Fourth Hospital of Hebei Medical University, 12 Health Road, Shijiazhuang, Hebei, 050011, People's Republic of China.

出版信息

BMC Cardiovasc Disord. 2021 Nov 26;21(1):565. doi: 10.1186/s12872-021-02331-9.

DOI:10.1186/s12872-021-02331-9
PMID:34836509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8627071/
Abstract

BACKGROUND

The diagnosis of malignant pericardial effusion (MPE) is often associated with a poor prognosis, but due to the complexity and unspecific nature of MPE patients' clinical manifestations, imaging often performs an essential role in diagnosis and prognosis.

METHODS

Patients diagnosed with MPE between 2013 and 2018 at one tumor hospital were included and followed up. The data covered the basic clinical features, imaging findings, treatments and prognosis of patients with MPE, and the factors that may have affected the prognosis were explored.

RESULTS

A total of 216 patients with MPE were included with the median age of 60 years. The most common primary cancer type was lung cancer (73.6%), the most common symptom was dyspnea (62.9%) and the most common abnormal electrocardiogram finding was sinus tachycardia (42.1%). The median survival time of the 216 patients with MPE was 13.7 months. The factors affecting prognosis were echocardiographic fluid signs (HR = 2.37, P = 0.010), electrocardiographic evidence of sinus tachycardia (HR = 1.76, P = 0.006) and echocardiographic evidence of cardiac tamponade (HR = 3.33, P < 0.001).

CONCLUSIONS

MPE has complex clinical manifestations and an unsatisfactory prognosis. Echocardiographic fluid signs, electrocardiographic evidence of sinus tachycardia, and echocardiographic evidence of cardiac tamponade are independent risk factors affecting prognosis.

摘要

背景

恶性心包积液(MPE)的诊断通常与预后不良相关,但由于 MPE 患者临床表现的复杂性和非特异性,影像学在诊断和预后中经常发挥重要作用。

方法

纳入一家肿瘤医院 2013 年至 2018 年间诊断为 MPE 的患者并进行随访。该数据涵盖了 MPE 患者的基本临床特征、影像学表现、治疗和预后,探索了可能影响预后的因素。

结果

共纳入 216 例 MPE 患者,中位年龄为 60 岁。最常见的原发性癌症类型是肺癌(73.6%),最常见的症状是呼吸困难(62.9%),最常见的异常心电图表现是窦性心动过速(42.1%)。216 例 MPE 患者的中位生存时间为 13.7 个月。影响预后的因素有心包积液超声征象(HR=2.37,P=0.010)、窦性心动过速的心电图证据(HR=1.76,P=0.006)和心包填塞的超声征象(HR=3.33,P<0.001)。

结论

MPE 临床表现复杂,预后不佳。超声心动图积液征象、心电图窦性心动过速证据和超声心动图心包填塞证据是影响预后的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8176/8627071/08c7fee5fe58/12872_2021_2331_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8176/8627071/08c7fee5fe58/12872_2021_2331_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8176/8627071/08c7fee5fe58/12872_2021_2331_Fig1_HTML.jpg

相似文献

1
Prognosis and role of clinical and imaging features in patients with malignant pericardial effusion: a single-center study in China.恶性心包积液患者的临床和影像学特征的预后和作用:中国单中心研究。
BMC Cardiovasc Disord. 2021 Nov 26;21(1):565. doi: 10.1186/s12872-021-02331-9.
2
Risk factors affecting the survival rate in patients with symptomatic pericardial effusion undergoing surgical intervention.影响有症状心包积液患者手术干预后生存率的危险因素。
Interact Cardiovasc Thorac Surg. 2013 Apr;16(4):495-500. doi: 10.1093/icvts/ivs491. Epub 2012 Dec 18.
3
Role of a 12-lead electrocardiogram in the diagnosis of cardiac tamponade as diagnosed by transthoracic echocardiography in patients with malignant pericardial effusion.12导联心电图在经胸超声心动图诊断恶性心包积液患者心脏压塞中的作用
Clin Cardiol. 2015 Mar;38(3):139-44. doi: 10.1002/clc.22370. Epub 2015 Feb 18.
4
[Malignant pericardial effusion--a sign of unfavorable prognosis?].[恶性心包积液——预后不良的标志?]
Schweiz Med Wochenschr. 1986 Mar 22;116(12):366-70.
5
Hypothyroid cardiac tamponade: clinical features, electrocardiography, pericardial fluid and management.甲状腺功能减退性心脏压塞:临床特征、心电图、心包积液和处理。
Am J Med Sci. 2010 Oct;340(4):276-81. doi: 10.1097/MAJ.0b013e3181e664c6.
6
[Treatment of malignant pericardial effusion].[恶性心包积液的治疗]
Med Klin (Munich). 1997 Dec;92 Suppl 5:27-30. doi: 10.1007/BF03041976.
7
Novel echocardiographic prognostic markers for cardiac tamponade in patients with large malignant pericardial effusions: A paradigm shift from flow to tissue imaging.大型恶性心包积液患者心脏压塞的新型超声心动图预后标志物:从血流成像到组织成像的范式转变
Echocardiography. 2017 Sep;34(9):1315-1323. doi: 10.1111/echo.13620. Epub 2017 Jul 7.
8
Diagnostic value of echocardiography in cardiac tamponade.超声心动图在心脏压塞中的诊断价值。
Herz. 2000 Dec;25(8):734-40. doi: 10.1007/pl00001991.
9
Cardiac tamponade in the pediatric oncology population: treatment by percutaneous catheter drainage.儿科肿瘤患者的心脏压塞:经皮导管引流治疗
J Pediatr Surg. 1996 Jan;31(1):197-9; discussion 199-200. doi: 10.1016/s0022-3468(96)90347-4.
10
[Clinical and laboratory features of patients with pericardial effusion].[心包积液患者的临床及实验室特征]
Turk Kardiyol Dern Ars. 2010 Oct;38(7):473-9.

引用本文的文献

1
Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk.接受第一代和第二代布鲁顿酪氨酸激酶抑制剂治疗的患者的心包炎和心脏压塞:一种未被充分认识的风险。
Case Rep Hematol. 2024 Jul 9;2024:2312182. doi: 10.1155/2024/2312182. eCollection 2024.
2
Development and validation a simple scoring system to identify malignant pericardial effusion.开发并验证一种用于识别恶性心包积液的简单评分系统。
Front Oncol. 2022 Dec 1;12:1012664. doi: 10.3389/fonc.2022.1012664. eCollection 2022.

本文引用的文献

1
Pericardial Involvement in Cancer.心包累及癌症。
Am J Cardiol. 2021 Apr 15;145:151-159. doi: 10.1016/j.amjcard.2020.12.092. Epub 2021 Jan 15.
2
Reduction of pericardial effusion in advanced non-small cell lung cancer patients with KRAS, TP53, and MET mutation treated with nivolumab.纳武利尤单抗治疗 KRAS、TP53 和 MET 突变的晚期非小细胞肺癌患者的心包积液减少。
J Int Med Res. 2020 Aug;48(8):300060520937490. doi: 10.1177/0300060520937490.
3
Serum BNP levels are associated with malignant pericardial effusion.血清脑钠肽水平与恶性心包积液相关。
Int J Cardiol Heart Vasc. 2019 Apr 9;23:100359. doi: 10.1016/j.ijcha.2019.100359. eCollection 2019 Jun.
4
Imaging of Pericardial Disease.心包疾病的影像学检查
Radiol Clin North Am. 2019 Jan;57(1):179-199. doi: 10.1016/j.rcl.2018.09.001.
5
Oncologic Emergencies: Recognition and Initial Management.肿瘤急症:识别与初步处理。
Am Fam Physician. 2018 Jun 1;97(11):741-748.
6
Total electrical alternans in a patient with malignant pericardial tamponade.一名恶性心包填塞患者出现完全性电交替。
BMJ Case Rep. 2018 Jul 19;2018:bcr-2018-224771. doi: 10.1136/bcr-2018-224771.
7
Comprehensive review of the epidemiology and treatments for malignant adult cardiac tumors.成人恶性心脏肿瘤的流行病学与治疗方法综述
Gen Thorac Cardiovasc Surg. 2018 May;66(5):257-262. doi: 10.1007/s11748-018-0912-3. Epub 2018 Mar 28.
8
A case report of lung adenocarcinoma with polyserous effusions as the onset symptom.以多浆膜腔积液为首发症状的肺腺癌病例报告
Medicine (Baltimore). 2017 Sep;96(36):e7867. doi: 10.1097/MD.0000000000007867.
9
Novel echocardiographic prognostic markers for cardiac tamponade in patients with large malignant pericardial effusions: A paradigm shift from flow to tissue imaging.大型恶性心包积液患者心脏压塞的新型超声心动图预后标志物:从血流成像到组织成像的范式转变
Echocardiography. 2017 Sep;34(9):1315-1323. doi: 10.1111/echo.13620. Epub 2017 Jul 7.
10
Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea.韩国恶性胸膜间皮瘤及胸膜转移瘤的多排螺旋CT表现与鉴别诊断
Korean J Radiol. 2016 Jul-Aug;17(4):545-53. doi: 10.3348/kjr.2016.17.4.545. Epub 2016 Jun 27.